Cohort study

Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair

JACC Cardiovasc IntervPublished

  • Retrospective registry analysis
  • CUTTING-EDGE registry

Median follow-up 9.1 months (IQR: 1.1-25.8 months) after surgery

Authors' conclusion

The risk of MV surgery after TEER is nontrivial, with higher mortality after surgery, especially in SMR patients.

Study context

Population
Patients undergoing mitral valve (MV) surgery after failed transcatheter edge-to-edge repair (TEER), July 2009–July 202047% primary (PMR), 53.0% SMR
Participants
330 patients
Exposure
SMR vs PMR in MV surgery after failed TEER
Outcome
MVARC outcomes
Follow-up
30 days and 1 year

Main finding

As reported in the abstract

Mortality

30-day mortality

P = 0.072

1-year mortality

P = 0.019

OutcomePMRSMRP value
30-day observed-to-expected mortality ratio2.6 (95% CI: 1.2-4.0)4.6 (95% CI: 2.6-6.6)
30-day observed-to-expected mortality ratio, overall
3.6 (95% CI: 1.9-5.3)

Observational data: associations, not effects.

Further findings

Aborted TEER, surgery for mitral stenosis after TEER, MV repair

Aborted TEER

P = 0.043

Surgery for mitral stenosis

P = 0.008

MV repair

P = 0.019

Original publication

Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Interv. Published 22 May 2023. doi:10.1016/j.jcin.2023.02.029

Summarised from the published abstract; every number is checked against it